An atlas of active enhancers across human cell types and tissues
Open accessThe DOI matches its Crossref record; 80 of the 81 references it cites were found in a registry or an index.
Abstract
Enhancers control the correct temporal and cell-type-specific activation of gene expression in multicellular eukaryotes. Knowing their properties, regulatory activity and targets is crucial to understand the regulation of differentiation and homeostasis. Here we use the FANTOM5 panel of samples, covering the majority of human tissues and cell types, to produce an atlas of active, in vivo-transcribed enhancers. We show that enhancers share properties with CpG-poor messenger RNA promoters but produce bidirectional, exosome-sensitive, relatively short unspliced RNAs, the generation of which is strongly related to enhancer activity. The atlas is used to compare regulatory programs between different cells at unprecedented depth, to identify disease-associated regulatory single nucleotide polymorphisms, and to classify cell-type-specific and ubiquitous enhancers. We further explore the utility of enhancer redundancy, which explains gene expression strength rather than expression patterns. The online FANTOM5 enhancer atlas represents a unique resource for studies on cell-type-specific enhancers and gene regulation. Using the FANTOM5 CAGE expression atlas, the authors show that bidirectional capped RNAs are a signature feature of active enhancers and identify over 40,000 enhancer candidates from over 800 human cell and tissue samples across the whole human body. FANTOM5 (standing for functional annotation of the mammalian genome 5) is the fifth major stage of a major international collaboration that aims to dissect the transcriptional regulatory networks that define every human cell type. Two Articles in this issue of Nature present some of the project's latest results. The first paper uses the FANTOM5 panel of tissue and primary cell samples to define an atlas of active, in vivo bidirectionally transcribed enhancers across the human body. These authors show that bidirectional capped RNAs are a signature feature of active enhancers and identify more than 40,000 enhancer candidates from over 800 human cell and tissue samples. The enhancer atlas is used to compare regulatory programs between different cell types and identify disease-associated regulatory SNPs, and will be a resource for studies on cell-type-specific enhancers. In the second paper, single-molecule sequencing is used to map human and mouse transcription start sites and their usage in a panel of distinct human and mouse primary cells, cell lines and tissues to produce the most comprehensive mammalian gene expression atlas to date. The data provide a plethora of insights into open reading frames and promoters across different cell types in addition to valuable annotation of mammalian cell-type-specific transcriptomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although enriched, histone modification and cofactor binding is not completely predictive of enhancer activity54,58,72,77,105.”
From Towards a comprehensive catalogue of validated and target-linked human enhancers (2020) · cites this paper as [58]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The majority of active enhancers are themselves transcribed, producing enhancer RNAs (eRNAs) in a bi-directional manner [73–77].”
From Transcriptional enhancers and their communication with gene promoters (2021) · cites this paper as [74]
The cited source says what the claim attributes to it.
In the citing paper
“In terms of their sequence properties, enhancers and promoters tend to differ in GC content, with many promoters and only a subset of enhancers containing CpG islands [74, 249].”
From Transcriptional enhancers and their communication with gene promoters (2021) · cites this paper as [74]
The cited source says what the claim attributes to it.
In the citing paper
“We filtered intragenic CAGE TCs with GG-initiation and those overlapping with coding exons and annotated enhancers24,70”
From Alternative promoters in CpG depleted regions are prevalently associated with epigenetic misregulation of liver cancer transcriptomes (2023) · cites this paper as [24]
In the citing paper
“as regulatory elements are subject to positive selection pressure, we identified sequences showing the highest conservation across mammalian species, including humans25–29.”
From Viral manipulation of functionally distinct interneurons in mice, non-human primates and humans (2020) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364 · cited 1×
“These were grouped according to Hela-S3 expression tertiles: low (36), mid-level (41) and strong (46).”
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
Regularization Paths for Generalized Linear Models via Coordinate Descent
Friedman, J., Hastie, T., & Tibshirani, R. (2010) · Journal of Statistical Software · doi:10.18637/jss.v033.i01 · Cited by 19,927
Model-based Analysis of ChIP-Seq (MACS)
Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-9-r137 · Cited by 18,386
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M. J., Salzberg, S. L., Wold, B. J., & Pachter, L. (2010) · Nature Biotechnology · doi:10.1038/nbt.1621 · Cited by 15,556
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382 · cited 1×
“These were grouped according to Hela-S3 expression tertiles: low (36), mid-level (41) and strong (46).”
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,617
Cited by
Items 501–600 of 1,017
Genomic benchmarks: a collection of datasets for genomic sequence classification
(2023) · doi:10.1186/s12863-023-01123-8 · Cited by 74
“The Human enhancers Ensembl dataset eas constructed from Human enhancers from The FANTOM5 project Andersson et al. (2014) accessed through the Ensembl database Howe et al.”
BackgroundMethodInfluentialLong non‐coding RNAs in corticogenesis: deciphering the non‐coding code of the brain
Aprea, J., & Calegari, F. (2015) · The EMBO Journal · doi:10.15252/embj.201592655 · Cited by 74
“…have been shown to be transcribed bidirectionally, producing short, unspliced, unpolyadenylated and unstable (exosome sensitive) eRNAs (Table 1) preceding the activation of the genes under control of the enhancer (Kim et al , 2010; Koch et al , 2011; Andersson et al , 2014; Arner et al , 2015).”
Deviatiiarov, R. M., Gams, A., Kulakovskiy, I. V., Buyan, A., Meshcheryakov, G., Syunyaev, R. A., Singh, R., Shah, P. M., Tatarinova, T. V., Gusev, O., et al. (2023) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00182-x · Cited by 77
Enhancer RNAs (eRNAs): New Insights into Gene Transcription and Disease Treatment
Ding, M., Liu, Y., Liao, X., Zhan, H., Liu, Y., & Huang, W. (2018) · Journal of Cancer · doi:10.7150/jca.25829 · Cited by 80
“Large-scale analysis demonstrated a positive correlation between the expression level of eRNAs and target[43] or nearby genes[14, 20].”
BackgroundAutomated in situ chromatin profiling efficiently resolves cell types and gene regulatory programs
Janssens, D. H., Wu, S. J., Sarthy, J. F., Meers, M. P., Myers, C. H., Olson, J. M., Ahmad, K., & Henikoff, S. (2018) · Epigenetics & Chromatin · doi:10.1186/s13072-018-0243-8 · Cited by 73
Fatemi, R. P., Velmeshev, D., & Faghihi, M. A. (2014) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2014.45 · Cited by 78
Leveraging Distant Relatedness to Quantify Human Mutation and Gene-Conversion Rates
Palamara, P. F., Francioli, L. C., Wilton, P., Genovese, G., Gusev, A., Finucane, H. K., Sankararaman, S., Sunyaev, S. R., de Bakker, P. I. W., Wakeley, J., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.10.006 · Cited by 80
Perenthaler, E., Yousefi, S., Niggl, E., & Barakat, T. S. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00352 · Cited by 81
Enhancer RNA: What we know and what we can achieve
Han, Z., & Li, W. (2022) · Cell Proliferation · doi:10.1111/cpr.13202 · Cited by 100
Selective gene expression maintains human tRNA anticodon pools during differentiation
Gao, L., Behrens, A., Rodschinka, G., Forcelloni, S., Wani, S., Strasser, K., & Nedialkova, D. D. (2024) · Nature Cell Biology · doi:10.1038/s41556-023-01317-3 · Cited by 89
Primate optogenetics: Progress and prognosis
El-Shamayleh, Y., & Horwitz, G. D. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1902284116 · Cited by 87
“Other assays take advantage of the facts that gene regulatory elements are often located in regions of open chromatin (95, 96), are transcribed (97, 98), and are bound to particular proteins (99).”
BackgroundHevener, A. L., Zhou, Z., Moore, T. M., Drew, B. G., & Ribas, V. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.06.013 · Cited by 72
A Two-Layered Targeting Mechanism Underlies Nuclear RNA Sorting by the Human Exosome
Wu, G., Schmid, M., Rib, L., Polak, P., Meola, N., Sandelin, A., & Jensen, T. H. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.068 · Cited by 72
“We and others have suggested previously that TSS-proximal PASs direct, at least in part, PROMPT and eRNA 3 0 end formation in preparation for exosome targeting (Almada et al., 2013; Andersson et al., 2014a; Ntini et al., 2013).”
BackgroundSelf-citationHost methylation predicts SARS-CoV-2 infection and clinical outcome
Konigsberg, I. R., Barnes, B., Campbell, M., Davidson, E., Zhen, Y., Pallisard, O., Boorgula, M. P., Cox, C., Nandy, D., Seal, S., et al. (2021) · Communications Medicine · doi:10.1038/s43856-021-00042-y · Cited by 84
Behind the scenes: How RNA orchestrates the epigenetic regulation of gene expression
Mangiavacchi, A., Morelli, G., & Orlando, V. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1123975 · Cited by 81
“In the last decade, the finding that enhancers can be actively transcribed led to the identification of a heterogenous class of regulatory non-coding transcripts, termed enhancer RNAs (eRNAs), whose importance in gene regulation has often been debated. eRNAs are short (median 346 nt), unstable, and unspliced nuclear-r…”
BackgroundThe DDBJ Japanese Genotype-phenotype Archive for genetic and phenotypic human data
Kodama, Y., Mashima, J., Kosuge, T., Katayama, T., Fujisawa, T., Kaminuma, E., Ogasawara, O., Okubo, K., Takagi, T., & Nakamura, Y. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1120 · Cited by 80
“vulgare); and raw and aligned transcriptomic reads from a majority of mammalian primary cell types analyzed by the FANTOM5 consortium (11,12).”
BackgroundYoung genes have distinct gene structure, epigenetic profiles, and transcriptional regulation
Werner, M. S., Sieriebriennikov, B., Prabh, N., Loschko, T., Lanz, C., & Sommer, R. J. (2018) · Genome Research · doi:10.1101/gr.234872.118 · Cited by 70
“…were originally thought of as inactive DNA elements that harbor TFBSs (Wasylyk 1988); however, over the last decade, research from several laboratories has shown that enhancers exhibit bidirectional transcription by RNA polymerase (Chen et al. 2013a; Andersson et al. 2014; Lam et al. 2014).”
Quantitative prediction of enhancer–promoter interactions
Belokopytova, P. S., Nuriddinov, M. A., Mozheiko, E. A., Fishman, D., & Fishman, V. (2020) · Genome Research · doi:10.1101/gr.249367.119 · Cited by 72
“jp/data/) (Andersson et al. 2014) and represents a map of human regulatory elements of each cellular state.”
BackgroundEnhancer RNA: Biogenesis, function, and regulation
Ye, R., Cao, C., & Xue, Y. (2020) · Essays in Biochemistry · doi:10.1042/ebc20200014 · Cited by 71
Benton, M. L., Talipineni, S. C., Kostka, D., & Capra, J. A. (2019) · BMC Genomics · doi:10.1186/s12864-019-5779-x · Cited by 75
Fitz, J., Neumann, T., Steininger, M., Wiedemann, E.-M., Garcia, A. C., Athanasiadis, A., Schoeberl, U. E., & Pavri, R. (2020) · Nature Genetics · doi:10.1038/s41588-020-0605-6 · Cited by 76
Discovery of genomic loci of the human cerebral cortex using genetically informed brain atlases
Makowski, C., van der Meer, D., Dong, W., Wang, H., Wu, Y., Zou, J., Liu, C., Rosenthal, S. B., Hagler, D. J., Fan, C. C., et al. (2022) · Science · doi:10.1126/science.abe8457 · Cited by 67
Studying Transcriptional Enhancers: The Founder Fallacy, Validation Creep, and Other Biases
Halfon, M. S. (2019) · Trends in Genetics · doi:10.1016/j.tig.2018.11.004 · Cited by 71
Approaches and advances in the genetic causes of autoimmune disease and their implications
Inshaw, J. R. J., Cutler, A. J., Burren, O. S., Stefana, M. I., & Todd, J. A. (2018) · Nature Immunology · doi:10.1038/s41590-018-0129-8 · Cited by 70
Dynamic chromatin regulatory landscape of human CAR T cell exhaustion
Gennert, D. G., Lynn, R. C., Granja, J. M., Weber, E. W., Mumbach, M. R., Zhao, Y., Duren, Z., Sotillo, E., Greenleaf, W. J., Wong, W. H., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2104758118 · Cited by 75
“We found that the majority of peaks at gene promoters were found in both species, while the majority of peaks found at intergenic, intronic, and regions overlapping with the Fantom5 CD4 T cell enhancer list (45) were largely unique to either human or mouse, both with and without homologous sequences across species (Fi…”
Intergenic disease-associated regions are abundant in novel transcripts
Bartoniček, N., Clark, M. B., Quek, X. C., Torpy, J., Pritchard, A. L., Mååg, J. L. V., Gloss, B., Crawford, J., Taft, R. J., Hayward, N. K., et al. (2017) · Genome biology · doi:10.1186/s13059-017-1363-3 · Cited by 76
“Enhancer RNAs, whether polyadenylated or not, can be unidirectionally transcribed from enhancer regions (1D eRNAs) or more commonly in a bidirectional manner [81].”
BackgroundDedifferentiation and neuronal repression define familial Alzheimer’s disease
Caldwell, A. B., Liu, Q., Schroth, G. P., Galasko, D. R., Yuan, S. H., Wagner, S. L., & Subramaniam, S. (2020) · Science Advances · doi:10.1126/sciadv.aba5933 · Cited by 69
“Enhancerassociated ATAC-seq regions were defined differential peaks occurring within the region list of TSS-associated enhancers generated by the FANTOM5 project (42), finding the intersecting DNA regions with the join_overlap_inner function in the plyranges R package (86).”
Dincer, A., Gavin, D. P., Xu, K., Zhang, B., Dudley, J. T., Schadt, E. E., & Akbarian, S. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.169 · Cited by 69
Spirits in the Material World: Enhancer RNAs in Transcriptional Regulation
Hou, T. Y., & Kraus, W. L. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.08.007 · Cited by 70
“eRNAs are relatively unstable compared to mRNAs and lncRNAs [45, 58, 60, 74, 77–79], and can be rapidly degraded by the exosome complex soon after synthesis [39, 73, 80, 81] (Fig.”
BackgroundMethodInfluentialPregnancy, preeclampsia and maternal aging: From epidemiology to functional genomics
Miller, E. C., Wilczek, A., Bello, N. A., Tom, S. E., Wapner, R. J., & Suh, Y. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101535 · Cited by 83
Whole genome sequence analysis of blood lipid levels in >66,000 individuals
Selvaraj, M. S., Li, X., Li, Z., Pampana, A., Zhang, D. Y., Park, J., Aslibekyan, S., Bis, J. C., Brody, J. A., Cade, B. E., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33510-7 · Cited by 69
Self-citationThe chromatin signatures of enhancers and their dynamic regulation
Barral, A., & Déjardin, J. (2023) · Nucleus · doi:10.1080/19491034.2022.2160551 · Cited by 86
“In addition there are multiple examples reporting that some enhancers can contact several promoters simultaneously [57,95,99] whereas distinct enhancers can contact the same promoter [9,95,99], suggesting that multiple enhancers can also act together.”
BackgroundInfluentialLu, B., Chen, S., Guan, X., Chen, X., Du, Y., Yuan, J., Wang, J., Wu, Q., Zhou, L., Huang, X., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02295-w · Cited by 91
“Nota-bly, two enhancers chr19:13023589–13,024,232 and chr19:13048278–13,048,689, named E1 and E2, respectively, were identified in the Nira-SE region on FANTOM5 portal [22] (Fig.”
Weinstein, J. S., Lezon-Geyda, K., Maksimova, Y., Craft, S., Zhang, Y., Su, M., Schulz, V. P., Craft, J., & Gallagher, P. G. (2014) · Blood · doi:10.1182/blood-2014-06-582700 · Cited by 69
“Numerous studies characterizing enhancers in human lymphoid cells on a genome wide scale have been performed.(55-65) Despite their biologic relevance, data are not available for human primary Tfh cell enhancers, perhaps because of the difficulty in obtaining adequate samples for analysis.”
BackgroundZhao, Y., Liu, Q., Acharya, P., Stengel, K. R., Sheng, Q., Zhou, X., Kwak, H., Fischer, M. A., Bradner, J. E., Strickland, S. A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.032 · Cited by 69
Living Organisms Author Their Read-Write Genomes in Evolution
Shapiro, J. A. (2017) · Biology · doi:10.3390/biology6040042 · Cited by 72
Lysine demethylases KDM6A and UTY: The X and Y of histone demethylation
Gažová, I., Lengeling, A., & SUMMERS, K. M. (2019) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2019.04.012 · Cited by 93
“The high microsyntenic conservation of this cluster of genes 367 USP9Y+DDX3Y+UTY suggests that they might be co-regulated, possibly by the ‘testis-specific’ 368 non-coding element TTTY15 [77] which was identified as an enhancer in the FANTOM5 369 study [78].”
BackgroundGenome-wide analysis of enhancer RNA in gene regulation across 12 mouse tissues
Cheng, J., Pan, D. Z., Tsai, Z. T., & Tsai, H. (2015) · Scientific Reports · doi:10.1038/srep12648 · Cited by 78
Transcriptional regulation by promoters with enhancer function
Dao, L. T. M., & Spicuglia, S. (2018) · Transcription · doi:10.1080/21541264.2018.1486150 · Cited by 69
Tan, J. Y., Smith, A., da Silva, M. F., Matthey-Doret, C., Rueedi, R., Sönmez, R., Ding, D., Kutalik, Z., Bergmann, S., & Marques, A. C. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.009 · Cited by 73
Causal role of histone acetylations in enhancer function
Pradeepa, M. M. (2016) · Transcription · doi:10.1080/21541264.2016.1253529 · Cited by 86
Boulay, G., Awad, M. E., Riggi, N., Archer, T. C., Iyer, S., Boonseng, W. E., Rossetti, N. E., Naigles, B., Rengarajan, S., Volorio, A., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0844 · Cited by 81
Diminished nuclear RNA decay upon Salmonella infection upregulates antibacterial noncoding RNAs
Imamura, K., Takaya, A., Ishida, Y., Fukuoka, Y., Taya, T., Nakaki, R., Kakeda, M., Imamachi, N., Sato, A., Yamada, T., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201797723 · Cited by 72
Self-citationZhang, T., Wang, T., Niu, Q., Xu, L., Chen, Y., Gao, X., Gao, H., Zhang, L., Liu, G. E., Li, J., et al. (2022) · BMC Biology · doi:10.1186/s12915-022-01269-4 · Cited by 81
Self-citationChow, L. K.-Y., Chung, D. L., Tao, L., Chan, K. F., Tung, S. Y., Ngan, R. K., Ng, W. T., Lee, A. W. M., Yau, C. C., Kwong, D. L., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104357 · Cited by 77
Shared genetic variants suggest common pathways in allergy and autoimmune diseases
Kreiner‐Møller, E., Waage, J., Standl, M., Brix, S., Pers, T. H., Alves, A. C., Warrington, N. M., Tiesler, C. M. T., Fuertes, E., Franke, L., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.10.055 · Cited by 74
Global impact of somatic structural variation on the DNA methylome of human cancers
Zhang, Y., Yang, L., Kucherlapati, M. H., Hadjipanayis, A. G., Pantazi, A., Bristow, C. A., Lee, E. A., Mahadeshwar, H. S., Tang, J., Zhang, J., et al. (2019) · Genome biology · doi:10.1186/s13059-019-1818-9 · Cited by 74
Population-scale study of eRNA transcription reveals bipartite functional enhancer architecture
Kristjánsdóttir, K., Kwak, Y., Tippens, N. D., Lis, J. T., Kang, H. M., & Kwak, H. (2020) · Nature Communications · doi:10.1038/s41467-020-19829-z · Cited by 67
Models of global gene expression define major domains of cell type and tissue identity
Hutchins, A. P., Yang, Z., Li, Y., He, F., Fu, X., Wang, X., Li, D., Liu, K., He, J., Wang, Y., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx054 · Cited by 66
“In the future it will be desirable to build models of C/T and domain specification in human (67), and also from multiple levels of data, from promoter and enhancer data (22,68,69), to epigenomic data (70), and mass spectrometrybased techniques (71,72), such as in the integrative framework of Mogrify (73), and so build…”
BackgroundRepurposing of promoters and enhancers during mammalian evolution
Carelli, F. N., Liechti, A., Halbert, J., Warnefors, M., & Kaessmann, H. (2018) · Nature Communications · doi:10.1038/s41467-018-06544-z · Cited by 66
White, M. A. (2015) · Genomics · doi:10.1016/j.ygeno.2015.06.003 · Cited by 65
NanoPARE: parallel analysis of RNA 5′ ends from low-input RNA
Schon, M. A., Kellner, M. J., Plotnikova, A., Hofmann, F., & Nodine, M. D. (2018) · Genome Research · doi:10.1101/gr.239202.118 · Cited by 63
“For example, TSS profiling using cap analysis of gene expression (CAGE) led to the annotation of TSSs from polyadenylated mRNA and long noncoding RNA (Andersson et al. 2014; Hon et al. 2017).”
MethodInterpreting the impact of noncoding structural variation in neurodevelopmental disorders
D’haene, E., & Vergult, S. (2020) · Genetics in Medicine · doi:10.1038/s41436-020-00974-1 · Cited by 72
HeRA: an atlas of enhancer RNAs across human tissues
Zhang, Z., Hong, W., Ruan, H., Jing, Y., Li, S., Liu, Y., Wang, J., Li, W., Diao, L., & Han, L. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa940 · Cited by 79
“We collected TFBS based on ChIP-seq datasets from ENCODE project (https://www. encodeproject.org/) (33), and mapped them to those eR-NAs co-expressed with TFs accordingly.”
InfluentialHung, T.-C., Kingsley, D. M., & Boettiger, A. N. (2024) · Nature Genetics · doi:10.1038/s41588-023-01641-2 · Cited by 64
“P pairs were mapped using the correlation of mRNA and eRNA transcription in capped analysis of gene expression results across diverse human cell types 45 .”
Deep Feature Selection: Theory and Application to Identify Enhancers and Promoters
Li, Y., Chen, C., & Wasserman, W. W. (2015) · Lecture notes in computer science · doi:10.1007/978-3-319-16706-0_20 · Cited by 76
The identification of cis-regulatory elements: A review from a machine learning perspective
Li, Y., Chen, C., Kaye, A. M., & Wasserman, W. W. (2015) · Biosystems · doi:10.1016/j.biosystems.2015.10.002 · Cited by 73
“Using 351 features derived from sequences, a SVM-based ensemble method, named DEEP, has been developed in (Kleftogiannis et al., 2015) for the classification of enhancers (from the FANTOM5 enhancer atlas (Andersson et al., 2014)) and non-enhancers.”
BackgroundMethodInfluentialETO family protein Mtg16 regulates the balance of dendritic cell subsets by repressing Id2
Ghosh, H. S., Ceribelli, M., de Matos, I. G., Lazarovici, A., Bussemaker, H. J., Lasorella, A., Hiebert, S. W., Liu, K., Staudt, L. M., & Reizis, B. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20132121 · Cited by 76
“This region has no adjacent genes other than ID2 but was recently shown to contain multiple enhancers, including those specific for cDCs or monocytes (Andersson et al., 2014).”
BackgroundApplying CRISPR–Cas9 tools to identify and characterize transcriptional enhancers
Lopes, R., Korkmaz, G., & Agami, R. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.79 · Cited by 76
Smart-RRBS for single-cell methylome and transcriptome analysis
Gu, H., Raman, A. T., Wang, X., Gaiti, F., Chaligne, R., Mohammad, A. W., Arczewska, A., Smith, Z. D., Landau, D. A., Aryee, M. J., et al. (2021) · Nature Protocols · doi:10.1038/s41596-021-00571-9 · Cited by 61
Enhancer RNAs stimulate Pol II pause release by harnessing multivalent interactions to NELF
Gorbovytska, V., Kim, S.-K., Kuybu, F., Götze, M., Um, D., Kang, K., Pittroff, A., Brennecke, T., Schneider, L.-M., Leitner, A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29934-w · Cited by 80
“In contrast to the Nr4a1-(b) (1-100) fragment, the Nr4a1-(a) (1-100) fragment was considerably more effective in dissociating NELF (Kd=2.”
BackgroundMethodInfluentialHigh-density P300 enhancers control cell state transitions
Witte, S. J., Bradley, A., Enright, A. J., & Muljo, S. A. (2015) · BMC Genomics · doi:10.1186/s12864-015-1905-6 · Cited by 79
“It has been shown that transcription activity at enhancers is important for neighboring gene expression [58].”
Backgroundfor the Sequencing Initiative Suomi (SISu) Project, Chheda, H., Palta, P., Pirinen, M., McCarthy, S., Walter, K., Koskinen, S., Salomaa, V., Daly, M., Durbin, R., et al. (2017) · European Journal of Human Genetics · doi:10.1038/ejhg.2016.205 · Cited by 64
Zhu, Y., Tazearslan, C., & Suh, Y. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217713750 · Cited by 81
HEDD: Human Enhancer Disease Database
Wang, Z., Zhang, Q., Zhang, W., Lin, J.-R., Cai, Y., Mitra, J., & Zhang, Z. D. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx988 · Cited by 67
“The current release of HEDD makes available a total of 2 793 316 putative enhancers collected from three major genome / epigenome annotation projects: 399 124 from ENCODE (11) predicted jointly by two segmentation methods––ChromHMM and Segway (19), 65 359 from FANTOM5 (12,13) predicted by the cap analysis of gene expr…”
InfluentialMyogenin promoter‐associated lncRNA Myoparr is essential for myogenic differentiation
Hitachi, K., Nakatani, M., Takasaki, A., Ouchi, Y., Uezumi, A., Ageta, H., Inagaki, H., Kurahashi, H., & Tsuchida, K. (2019) · EMBO Reports · doi:10.15252/embr.201847468 · Cited by 68
“Enhancerderived lncRNAs, also known as eRNAs, are generally short, unstable, and bidirectional, and their generation is strongly associated with enhancer activity [2].”
Hoffman, G. E., Bendl, J. M., Girdhar, K., Schadt, E. E., & Roussos, P. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz808 · Cited by 78
Andrysik, Z., Bender, H., Galbraith, M. D., & Espinosa, J. M. (2021) · Nature Communications · doi:10.1038/s41467-021-21687-2 · Cited by 63
Rubin, J. D., Stanley, J. T., Sigauke, R. F., Levandowski, C. B., Maas, Z. L., Westfall, J., Taatjes, D. J., & Dowell, R. D. (2021) · Communications Biology · doi:10.1038/s42003-021-02153-7 · Cited by 63
GRaNIE and GRaNPA : inference and evaluation of enhancer‐mediated gene regulatory networks
Kamal, A., Arnold, C., Claringbould, A., Moussa, R., Servaas, N. H., Kholmatov, M., Daga, N., Nogina, D., Mueller‐Dott, S., Reyes‐Palomares, A., et al. (2023) · Molecular Systems Biology · doi:10.15252/msb.202311627 · Cited by 63
“We obtained the tracks of human enhancers identified using CAGE data from FANTOM5 that were differentially expressed in T-cells and macrophages (Andersson et al , 2014).”
BackgroundMethodInfluentialThe correlation between CpG methylation and gene expression is driven by sequence variants
Stefánsson, Ó. A., Sigurpalsdottir, B. D., Rögnvaldsson, S., Halldorsson, G. H., Juliusson, K., Sveinbjörnsson, G., Gunnarsson, B., Beyter, D., Jónsson, H., Gudjonsson, S. A., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01851-2 · Cited by 79
“We further confirmed the well-documented lack of 5-mCpGs in functional regions mapped by Encode 33 and others 34,35 (Fig.”
SpDamID: Marking DNA Bound by Protein Complexes Identifies Notch-Dimer Responsive Enhancers
Hass, M. R., Liow, H.-H., Chen, X., Sharma, A., Inoue, Y., Inoue, T., Reeb, A. N., Martens, A., Fulbright, M. C., Raju, S., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.008 · Cited by 68
“HOMER analysis of the Notch SpDamID microarray (Figure S2D and S2E) or SpDamID-seq libraries (Figure 2B) identified the known RBP motif (BVYGDGAD) as being significantly enriched (N1D/RBP p<10−138, N1/MAML p<10−172, and N1/p300 p<10−182) ranking second to the AP1 motif consistent with the observation that AP1 sites ar…”
BackgroundRahman, S., Zorca, C. E., Traboulsi, T., Noutahi, E., Krause, M. R., Mader, S., & Zenklusen, D. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1220 · Cited by 80
“a median length of ∼350 nucleotides (19).”
Long non-coding RNAs as novel players in β cell function and type 1 diabetes
Mirza, A. H., Kaur, S., & Pociot, F. (2017) · Human Genomics · doi:10.1186/s40246-017-0113-7 · Cited by 67
Huang, Y., Mouttet, B., Warnatz, H.-J., Risch, T., Rietmann, F., Frommelt, F., Ngo, Q. A., Dobay, M. P., Marovca, B., Jenni, S., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.10.004 · Cited by 64
Implications of Enhancer Transcription and eRNAs in Cancer
Adhikary, S., Roy, S., Chacon, J. A., Gadad, S. S., & Das, C. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-4010 · Cited by 70
“BruUV-seq, which involves the transcription blocking of DNA lesions using UV light coupled with bromouridine labeling and nascent RNA-seq, is also an efficient method to detect eRNAs (51).”
BackgroundInfluentialBig data and deep learning for RNA biology
Hwang, H., Jeon, H., Yeo, N., & Baek, D. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01243-w · Cited by 73
“The FANTOM database provides atlases of gene regulatory elements and noncoding RNAs 30,31 .”
MethodMa, M., Ru, Y., Chuang, L.-S. F., Hsu, N.-Y., Shi, L., Hakenberg, J., Cheng, W., Uzilov, A. V., Ding, W., Glicksberg, B. S., et al. (2015) · BMC Genomics · doi:10.1186/1471-2164-16-s8-s3 · Cited by 70
“The Mendelian disease variants were collected from OMIM and ClinVar, and the promoter elements from the FANTOM5 project.”
MethodInfluentialTranscriptional Dynamics Reveal Critical Roles for Non-coding RNAs in the Immediate-Early Response
Aitken, S., Magi, S., Alhendi, A. M. N., Itoh, M., Kawaji, H., Lassmann, T., Daub, C. O., Arner, E., Carninci, P., Forrest, A. R. R., et al. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004217 · Cited by 66
“Multiple enhancer expression values arising from the many-to-many assignment of distal enhancers to genes [19, 39] were associated with genes by averaging.”
Self-citationCAGEfightR: analysis of 5′-end data using R/Bioconductor
Thodberg, M., Thieffry, A., Vitting‐Seerup, K., Andersson, R., & Sandelin, A. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-3029-5 · Cited by 72
Self-citationQamra, A., Xing, M., Padmanabhan, N., Kwok, J. J. T., Zhang, S., Xu, C., Leong, Y. S., Lim, A. P. L., Tang, Q., Ooi, W. F., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1022 · Cited by 68
Cis and trans effects differentially contribute to the evolution of promoters and enhancers
Mattioli, K., Oliveros, W., Gerhardinger, C., Andergassen, D., Maass, P. G., Rinn, J. L., & Melé, M. (2020) · Genome biology · doi:10.1186/s13059-020-02110-3 · Cited by 83
“Indeed, previous work by the FANTOM5 consortium has shown that on average, genes only have ~ 2 TSSs but are regulated by ~ 5 transcribed enhancers [33].”
BackgroundMethodInfluentialMassively parallel high-order combinatorial genetics in human cells
Wong, A. S. L., Choi, G. C. G., Cheng, A. A., Purcell, O., & Lu, T. K. (2015) · Nature Biotechnology · doi:10.1038/nbt.3326 · Cited by 65
Kambara, H., Gunawardane, L. S., Zebrowski, E., Kostadinova, L., Jobava, R., Krokowski, D., Hatzoglou, M., Anthony, D. D., & Valadkhan, S. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00676 · Cited by 63
Siggens, L., Cordeddu, L., Rönnerblad, M., Lennartsson, A., & Ekwall, K. (2015) · Epigenetics & Chromatin · doi:10.1186/1756-8935-8-4 · Cited by 75
“Active enhancers are also identified by Pol II transcription [54].”
BackgroundSelf-citationThe Role of H3K4me3 in Transcriptional Regulation Is Altered in Huntington’s Disease
Dong, X., Tsuji, J., Labadorf, A. T., Roussos, P., Chen, J., Myers, R. H., Akbarian, S., & Weng, Z. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144398 · Cited by 75
Rojo, R., Pridans, C., Langlais, D., & Hume, D. A. (2017) · Clinical Science · doi:10.1042/cs20170238 · Cited by 60
Self-citationBidirectional transcription initiation marks accessible chromatin and is not specific to enhancers
Young, R. S., Kumar, Y., Bickmore, W. A., & Taylor, M. S. (2017) · Genome biology · doi:10.1186/s13059-017-1379-8 · Cited by 72
“While other approaches to detect enhancers use computational algorithms to remove some of this low-level transcription [13], this also vastly reduces the number of enhancers detected to orders of magnitude less than those detected by chromatin state annotation and thereby discards many genuine, but lowly transcribed,…”
InfluentialThe miR-96 and RARγ signaling axis governs androgen signaling and prostate cancer progression
Long, M. D., Singh, P. K., Russell, J. R., Llimos, G., Rosario, S. R., Rizvi, A., van den Berg, P. R., Kirk, J. S., Sucheston‐Campbell, L. E., Smiraglia, D. J., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0450-6 · Cited by 65
Demanelis, K., Argos, M., Lin, T., Shinkle, J., Sabarinathan, M., Rakibuz‐Zaman, M., Sarwar, G., Shahriar, H., Islam, T., Rahman, M., et al. (2019) · Environmental Health Perspectives · doi:10.1289/ehp3849 · Cited by 66
“UCSC genome (http://genome.ucsc.edu/), FANTOM5 (Andersson et al. 2014), and ENCODE (Thurman et al. 2012) annotations were provided by Illumina and used to annotate and assign genomic features to CpGs based on human reference genome GRCh37.”
Enhancer-Derived RNA: A Primer
Liu, F. (2017) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2016.12.006 · Cited by 64
“Pervasive RNA synthesis from enhancers was soon confirmed in the majority of human cell types and tissues through systematic characterization of the functional elements in the genome by the Functional Annotation of the Mammalian Genome (FANTOM) consortium [15] and the Encyclopedia of DNA Elements (ENCODE) consortium […”
BackgroundWinczura, K., Schmid, M., Iasillo, C., Molloy, K. R., Harder, L. M., Andersen, J. S., LaCava, J., & Jensen, T. H. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.037 · Cited by 60
“However, contacts from the CBC can also be established to the ribonucleolytic RNA exosome operating at Pol II-transcribed loci to degrade spurious transcripts like promoter upstream transcripts (PROMPTs) and enhancer RNA (eRNAs) (Andersen et al., 2013; Andersson et al., 2014; Ntini et al., 2013), or to participate in…”
BackgroundSelf-citationGenetic and Epigenetic Fine Mapping of Complex Trait Associated Loci in the Human Liver
Çalışkan, M., Manduchi, E., Rao, H. S., Segert, J. A., Beltrame, M. H., Trizzino, M., Park, Y., Baker, S. W., Chesi, A., Johnson, M. E., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.05.010 · Cited by 83
A mega-analysis of expression quantitative trait loci in retinal tissue
Strunz, T., Kiel, C., Graßmann, F., Ratnapriya, R., Kwicklis, M., Karlstetter, M., Fauser, S., Arend, N., Swaroop, A., Langmann, T., et al. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008934 · Cited by 66
“Alternatively, these findings in retina could be due to the co-localization with eQTL in clusters of retina-specific enhancers [17,18].”
BackgroundRoy, S., Schmeier, S., Arner, E., Alam, T., Parihar, S. P., Ozturk, M., Tamgue, O., Kawaji, H., de Hoon, M., Itoh, M., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv646 · Cited by 73
“It also identified active enhancer elements among these cell types (35).”
BackgroundSelf-citationARS2 is a general suppressor of pervasive transcription
Iasillo, C., Schmid, M., Yahia, Y., Maqbool, M. A., Descostes, N., Karadoulama, E., Bertrand, É., Andrau, J., & Jensen, T. H. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx647 · Cited by 62
“This is consistent with previous analysis (8,10,11,22,25,46) and establishes the exosome as a strict post-transcriptional player”
ResultSelf-citationPrediction of lncRNAs and their interactions with nucleic acids: benchmarking bioinformatics tools
Antonov, I., Mazurov, E., Borodovsky, M. Y., & Medvedeva, Y. A. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bby032 · Cited by 68
A genome-wide assessment of the ancestral neural crest gene regulatory network
Hockman, D., Chong-Morrison, V., Green, S. A., Gavriouchkina, D., Candido-Ferreira, I., Ling, I. T. C., Williams, R. M., Amemiya, C. T., Smith, J. J., Bronner-Fraser, M. E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12687-4 · Cited by 62
Hecker, N., & Hiller, M. (2020) · GigaScience · doi:10.1093/gigascience/giz159 · Cited by 60
“We downloaded the coordinates of the 38,548 robust FAN-TOM enhancers from SlideBase [57, 88].”
Li, K., Zhang, Y., Liu, X., Liu, Y., Gu, Z., Cao, H., Dickerson, K. E., Chen, M., Chen, W., Shao, Z., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1128 · Cited by 80
Self-citation
Metadata
- Authors
- The FANTOM Consortium, Andersson, R., Gebhard, C., Miguel-Escalada, I., Hoof, I., Bornholdt, J., Boyd, M., Chen, Y., Zhao, X., Schmidl, C., Suzuki, T., Ntini, E., Arner, E., Valen, E., Li, K., Schwarzfischer, L., Glatz, D., Raithel, J., Lilje, B., Rapin, N., Bagger, F. O., Jørgensen, M., Andersen, P. R., Bertin, N., Rackham, O., Burroughs, A. M., Baillie, J. K., Ishizu, Y., Shimizu, Y., Furuhata, E., Maeda, S., Negishi, Y., Mungall, C. J., Meehan, T. F., Lassmann, T., Itoh, M., Kawaji, H., Kondo, N., Kawai, J., Lennartsson, A., Daub, C. O., Heutink, P., Hume, D. A., Jensen, T. H., Suzuki, H., Hayashizaki, Y., Müller, F., Forrest, A. R. R., Carninci, P., Rehli, M., & Sandelin, A.
- Affiliations
- University of Copenhagen (DK)
- University Hospital Regensburg (DE)
- University of Birmingham (GB)
- University of North Carolina at Chapel Hill (US)
- RIKEN (JP)
- Aarhus University (DK)
- Roslin Institute (GB)
- European Bioinformatics Institute (GB)
- Karolinska Institutet (SE)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Corresponding author
- Forrest, Alistair R. R.
- Carninci, Piero
- Rehli, Michael
- Sandelin, Albin
- ORCID
- Andersson, Robin
- Gebhard, Claudia
- Miguel-Escalada, Irene
- Hoof, Ilka
- Bornholdt, Jette
- Chen, Yun
- Schmidl, Christian
- Suzuki, Takahiro
- Ntini, Evgenia
- Valen, Eivind
- Li, Kang
- Lilje, Berit
- Rapin, Nicolas
- Bagger, Frederik Otzen
- Andersen, Peter Refsing
- Bertin, Nicolas
- Rackham, Owen
- Burroughs, A. Maxwell
- Baillie, J. Kenneth
- Ishizu, Yuri
- Shimizu, Yuri
- Furuhata, Erina
- Meehan, Terrence F.
- Lassmann, Timo
- Itoh, Masayoshi
- Kawaji, Hideya
- Kawai, Jun
- Lennartsson, Andreas
- Daub, Carsten O.
- Heutink, Peter
- Hume, David A.
- Jensen, Torben Heick
- Suzuki, Harukazu
- Hayashizaki, Yoshihide
- Müller, Ferenc
- Forrest, Alistair R. R.
- Carninci, Piero
- Rehli, Michael
- Sandelin, Albin
- Venue
- Nature
- Published
- 2014-03
- Volume
- 507
- Issue
- 7493
- Pages
- 455-461
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5215096
- OpenAlex
- W2015845481
- Cited by
- 2,550
- References
- 81
- Citations by year
- 2026: 93 · 2025: 140 · 2024: 207 · 2023: 185 · 2022: 225 · 2021: 280 · 2020: 232 · 2019: 226 · 2018: 261 · 2017: 208 · 2016: 186 · 2015: 212 · 2014: 89
- FWCI
- 95.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (publishedVersion)
- PubMed Central (acceptedVersion)
- SDL (submittedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Griffith Research Online (submittedVersion)
- Funders
- Wellcome Trust (103258/Z/13/Z)
- European Commission (FP7/2007–2013/ERC, 2007–2013, FP7 2007-2013, FP7/2007)
- Deutsche Forschungsgemeinschaft (FP7/2007–2013)
- Ministry of Education, Culture, Sports, Science and Technology
- Lundbeckfonden (R167-2013-15058, R82-2010-6779)
- Novo Nordisk
- Novo Nordisk Fonden (NNF12OC0001211)
- H. Lundbeck A/S
- Biotechnology and Biological Sciences Research Council (BBS/E/D/20251969, BB/I024801/1)
- Japan Society for the Promotion of Science (24659373, 25330333, 22228005)
- RIKEN
- National Institute of Dental and Craniofacial Research (R01DE022969)
- FP7 Ideas: European Research Council (204135)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Keywords
- enhancers, bidirectional transcription, unspliced RNA, FANTOM5, CAGE, cell type-specific gene regulation, regulatory single nucleotide polymorphisms, enhancer redundancy, transcription start sites, promoter usage, human cell types, tissue-specific enhancers
- MeSH terms
- Atlases as Topic, Cell Line, Cells, Cultured, Enhancer Elements, Genetic, Gene Expression Regulation, HeLa Cells, Humans, Organ Specificity, Promoter Regions, Genetic, RNA, Messenger, Cluster Analysis, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Transcription Initiation Site, Molecular Sequence Annotation, Transcription Initiation, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.